Detalles de la búsqueda
1.
First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.
Trop Med Int Health
; 15(10): 1198-203, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20723184
2.
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.
Malar J
; 8: 198, 2009 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19674487
3.
Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors.
Malar J
; 6: 117, 2007 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17764568
4.
gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.
Parasit Vectors
; 6: 68, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23497646
5.
Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.
Trans R Soc Trop Med Hyg
; 106(8): 460-7, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22721883
6.
Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays.
Parasit Vectors
; 4: 212, 2011 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22059951
7.
Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control.
Am J Trop Med Hyg
; 83(1): 115-21, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20595489
Resultados
1 -
7
de 7
1
Próxima >
>>